Anupam Rasayan will acquire up to 74.2% stake in Bliss GVS Pharma, strengthening its presence across the pharmaceutical value chain and expanding its reach in regulated global markets.Read More
Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
- by stefan